Journals / ANKEM Dergisi / 2014 / Cilt: 28 - Sayı: 4

The Prevalence and Antibiotic Resistance Profiles of Mycoplasma hominis and Ureaplasma urealyticum at a University Hospital

BİR ÜNİVERSİTE HASTANESİNDE MYCOPLASMA HOMINIS VE UREAPLASMA UREALYTICUM PREVALANSI VE ANTİBİYOTİK DİRENÇ PROFİLİ

Pages
124–128
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, administration of appropriate treatment f or inf ections caused by U.urealyticum and M.hominis according to results of antimicrobial testing is important.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The most f requently isolated mycoplasmas f rom the urogenital tract are Ureaplasma urealyticum and Mycoplasma hominis.
📊
Key Findings & Data:Vaginal specimens that were sent to the microbiology laboratory of Turgut Özal University Hospital f rom the gynecology and obstet- rics outpatient clinic f rom 4391 patients with a prediagnosis of vaginitis between April 2011 and May 2014 were included in this study.
💡
Conclusion & Impact:In conclusion, administration of appropriate treatment f or inf ections caused by U.urealyticum and M.hominis according to results of antimicrobial testing is important.
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

The most f requently isolated mycoplasmas f rom the urogenital tract are Ureaplasma urealyticum and Mycoplasma hominis. The aim of this study was to determine the prevalance and antibiotic resistance prof iles of genital U.urealyticum and M.hominis in women with a prediagnosis of vaginitis. Vaginal specimens that were sent to the microbiology laboratory of Turgut Özal University Hospital f rom the gynecology and obstet- rics outpatient clinic f rom 4391 patients with a prediagnosis of vaginitis between April 2011 and May 2014 were included in this study. The samples were taken using sterile swab tubes with transport medium (Copan, Italy). The presence of M.hominis and U.urealyticum and the antimicrobial susceptibilities aganist doxycycline, of loxacine, erythromycin, tetracycline, ciprof loxacin, azithromycin, clarithromycin, josamy- cin and pristinamycin were determined using Mycoplasma IST 2 test (BioMérieux, France). While there wasn’t any growth in 3686 of patients, U.urealyticum was detected in 558 and, M.hominis was detected in 147 patients. The resistance rates of U.urealyticum were as f ollows: Ciprof loxacin 75.8 %, of loxacin 47.8 %, erythromycin 22 %, clarithromycin 19.7 %, azithromycin 15.6 %, josamycin 8.4 %, pristi- namycin 6.5 %, tetracycline 3.2 %, doxycycline 2 %. The resistance rates of M.hominis were as f ollows: Erythromycin 95.9 %, clarithromy- cin 89.1 %, ciprof loxacin 87.1 %, of loxacin 87.1 %, azithromycin 83 %, josamycin 25.8 %, pristinamycin 15 %, tetracycline 12.3 %, doxyc- ycline 6.8 %. Considering these results, highest rates of susceptibility of both microorganisms were to doxycycline, tetracycline, pristinamycin and josamycin, respectively. Although the activity of tetracycline antibiotics is high, potential side eff ects that may occur af ter treatment should be considered. Because the resistance rates of macrolide and quinolone antibiotics were high especially f or M.hominis, use of these is restricted in the treatment. In conclusion, administration of appropriate treatment f or inf ections caused by U.urealyticum and M.hominis according to results of antimicrobial testing is important.

Özet

Ürogenital sistemden en sık izole edilen mikoplazmalar Mycoplasma hominis ve Ureaplasma urealyticumdur. Çalışmamızın amacı vajinit ön tanılı kadın hastalarda genital U.urealyticum ve M.hominis sıklığının ve antibiyotik direnç prof ilinin belirlenmesidir. Çalışmaya Turgut Özal Üniversitesi Tıp Fakültesi Hastanesi Mikrobiyoloji Laboratuvarına Nisan 2011-Mayıs 2014 tarihleri arasın- da Kadın Hastalıkları ve Doğum Polikliniğine başvuran vajinit ön tanılı 4391 hastadan alınan vajen örnekleri dahil edilmiştir. Örnekler eküvyon ile alınarak steril taşıma besiyeri (Copan, İtalya) içinde laboratuvara gönderilmiştir. Mycoplasma IST 2 test (BioMérieux, Fransa) kiti kullanılarak M.hominis ve U.urealyticum varlığı ve üreme saptanan örneklerde etkenlerin doksisiklin, of loksasin, eritromisin, tetrasiklin, siprof loksasin, azitromisin, klaritromisin, josamisin ve pristinamisine duyarlılıkları belirlenmiştir. Örneklerin 3686ında üreme olmazken, 558sinde U.urealyticum ve 147‘sinde M.hominis izole edilmiştir. U.urealyticum suşlarında siprof loksasine % 75.8, of loksasine % 47.8, eritromisine % 22, klaritromisine % 19.7, azitromisine % 15.6, josamisine % 8.4, pristinamisine % 6.5, tetrasikline % 3.2, doksisikline % 2 direnç saptanmıştır. M.hominis suşlarında ise eritromisine % 95.9, klaritromisine % 89.1, siprof loksasine % 87.1, of loksasine % 87.1, azitro- misine % 83, josamisine % 25.8, pristinamisine % 15, tetrasikline % 12.3, doksisikline % 6.8 direnç bulunmuştur. Bu sonuçlar değerlendirildiğinde her iki mikroorganizmanın duyarlılığın en yüksek olduğu antimikrobiyaller sırasıyla doksisiklin, tetrasiklin, pristinamisin ve josamisin olarak saptanmıştır. Tetrasiklin grubu antibiyotiklere karşı duyarlılık yüksek olmasına rağmen tedavi sonrası oluşabilecek oluşabilecek yan etkiler göz önünde bulundurulmalıdır. Özellikle M.hoministe makrolid ve kinolon grubu antibiyotiklere direncin yüksek olması tedavide bu grup antibiyotiklerin kullanımını kısıtlamaktadır. Sonuç olarak M.hominis ve U.urealyticumun etken olduğu düşünülen inf eksiyonlarda yapılan antibiyogram test sonucuna göre uygun tedavinin verilmesi önem taşımaktadır.

🔖

Cite This Article

MERAL, T., ULUDAĞ, H. A., ARIBAŞ, E. T. (2014). The Prevalence and Antibiotic Resistance Profiles of Mycoplasma hominis and Ureaplasma urealyticum at a University Hospital. ANKEM Dergisi, Cilt: 28 - Sayı: 4, 124–128. https://ajindex.com/articles/355100

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Aguilera-Arreola MG, González-Cardel AM, Tenorio AM, Curiel-Quesada E, Castro-Escarpulli G. Highly specific and efficient primers for in-house multiplex PCR detection of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma hominis and Ureaplasma urealyticum, BMC Res Notes 2014;7:433.
  2. Aybar Bilir Y, Pehlivanoglu F, Kart Yasar K, Sengöz G. Prevalence of Mycoplasma hominis and Ureaplasma urealyticum in patients with uro- genital symptoms, Haseki Tıp Bült 2011;49(3):99- 101
  3. Biernat-Sudolska M, Rojek-Zakrzewska D, Zawiliñska B, Magdalena VK. The need to verify of positive Mycoplasma hominis results obtained using the Mycoplasma IST 2 tests, J of Lab Diag 2013;49(1):5-8
  4. Capoccia R, Greub G, Baud D. Ureaplasma ure- alyticum, Mycoplasma hominis and adverse preg- nancy outcomes, Curr Opin Inf ect Dis 2013;26(3): 231-40.
  5. Clinical and Laboratory Standards Institute. Methods for antimicrobial susceptibility testing for human mycoplasmas; Approved guideline, CLSI Document M43-A, CLSI, Wayne (2011)
  6. De Francesco MA, Caracciolo S, Bonfanti C, Manca N. Incidence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyti- cum isolated in Brescia, Italy, over 7 years, J Inf ect Chemother 2013;19(4):621-7.
  7. Ekşi F, Bayram A, Zer Y, Balcı I, Bayrak S, Aydınok Z. Servisitli kadınların endoservikal sürüntü örneklerinde Mycoplasma hominis ve Ureaplasma urealyticum araştırılması, Fırat Tıp Derg 2006;11(4):193-6
  8. Fiacco V, Miller MJ, Carney E, Martin WJ. Comparison of media for isolation of Ureaplasma urealyticum and genital Mycoplasma species, J Clin Microbiol 1984;20(5):862-5
  9. Gökahmetoğlu S, Özçelik B, Kütükoğlu I, Saatçi E, Özbal Y. Vajinal akıntısı olan kadınlarda Myco- plasma hominis ve Ureaplasma urealyticum sıklı- ğının ve antimikrobiyallere direnç durumunun belirlenmesi, Artemis 2004;5(2):159-61
  10. Lamont RF, Taylor-Robinson D, Wigglesworth JS, Furr PM, Evans RT, Elder MG. The role of mycop- lasmas, ureaplasmas and chlamydiae in the geni- tal tract of women presenting in spontaneous early preterm labour, J Med Microbiol 1987;24(3): 253-7.
  11. Redelinghuys MJ, Ehlers MM, Dreyer AW, Lombaard HA, Kock MM. Antimicrobial suscepti- bility patterns of Ureaplasma species and Mycoplasma hominis in pregnant women, BMC Inf ect Dis 2014;14:171. http://dx.doi.o